I had an idea. NP said in a recent video they will schedule a conference call soon. Maybe this board could come up with a list of questions to send NP before the call to address. We could have everyone give a rank for the questions and send NP the top 3-5 ranked. Also, if the other mods are fine we it, maybe we could email NP the question with all the mods signing the email, something like "Top 5 ranked CC questions from the Investors Hangout Board" emailed from the all the mods on the board. That might get his attention, maybe he would put some weight towards answering some.
So I will start with a few questions, feel free to jump in with questions. I think we need to ask pointed questions. Not when with the TNBC trial enroll the first patient, that is too generic. And we know the soon replay people hate.
But maybe for TNBC
Has anyone been screened for the TNBC trial yet?
or
What is delaying the other centers from starting in the mTNBC trial?
I see we have at least 4 big areas, combo, mono, mTNBC, Partnerships & funding, all of which we are waiting for more info. Maybe a question from each would be good, but still the ranking
Combo --
When do you anticipate an answer from the FDA on 525mg vs 700mg safety data?
or
You mention on (look up date) the BLA timeline should be firmed up soon, when do you anticipate to release this timeline?
Mono --
You gave a press release on June 7th saying the FDA requested an in-person meeting to discuss the mono trial. When do you anticipate announcing this meeting date?
mTNBC
Already given above
Partnerships & Funding
The second note becomes monthly convertible on July 30th. The first note's monthly conversions has put a strain on the share price, so two notes converting monthly would put a great strain on the share price. What is your plan to address this issue?
Post your questions, and if everyone is in agreement, after a few days, we can rank the questions.
So I will start with a few questions, feel free to jump in with questions. I think we need to ask pointed questions. Not when with the TNBC trial enroll the first patient, that is too generic. And we know the soon replay people hate.
But maybe for TNBC
Has anyone been screened for the TNBC trial yet?
or
What is delaying the other centers from starting in the mTNBC trial?
I see we have at least 4 big areas, combo, mono, mTNBC, Partnerships & funding, all of which we are waiting for more info. Maybe a question from each would be good, but still the ranking
Combo --
When do you anticipate an answer from the FDA on 525mg vs 700mg safety data?
or
You mention on (look up date) the BLA timeline should be firmed up soon, when do you anticipate to release this timeline?
Mono --
You gave a press release on June 7th saying the FDA requested an in-person meeting to discuss the mono trial. When do you anticipate announcing this meeting date?
mTNBC
Already given above
Partnerships & Funding
The second note becomes monthly convertible on July 30th. The first note's monthly conversions has put a strain on the share price, so two notes converting monthly would put a great strain on the share price. What is your plan to address this issue?
Post your questions, and if everyone is in agreement, after a few days, we can rank the questions.
3
